THC (Tenet Healthcare) ROCE % : 15.69% (As of Mar. 2025)

View and export this data going back to 1972. Start your Free Trial

What is Tenet Healthcare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tenet Healthcare's annualized ROCE % for the quarter that ended in Mar. 2025 was 15.69%.

Tenet Healthcare ROCE % Historical Data

The historical data trend for Tenet Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenet Healthcare ROCE % Chart

Tenet Healthcare Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

8.08

12.57

9.90

10.89

25.21

Tenet Healthcare Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															56.15	13.37	18.89	14.16	15.69

Tenet Healthcare ROCE % Calculation

Tenet Healthcare's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	6074	/	( ( (28312 - 4760)	+	(28936 - 4310) )	/ 2 )
	=	6074	/	( (23552	+	24626)	/ 2 )
	=	6074	/	24089
	=	25.21 %

Tenet Healthcare's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	3876	/	( ( (28936 - 4310)	+	(29237 - 4451) )	/ 2 )
	=	3876	/	( ( 24626	+	24786 )	/ 2 )
	=	3876	/	24706
	=	15.69 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Tenet Healthcare (NYSE:THC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tenet Healthcare ROCE % Related Terms

Thank you for viewing the detailed overview of Tenet Healthcare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenet Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tenet Healthcare Corp (NYSE:THC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

THC:Mexico 1THC:Italy THC1:Germany THC1:Germany

Address

14201 Dallas Parkway, Dallas, TX, USA, 75254

Website

https://www.tenethealth.com

Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Executives

J Robert Kerrey	director	NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
James L Bierman	director	9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA 23116
Richard W Fisher	director
Thomas W Arnst	officer: EVP, Chief Admin. Officer & GC	14201 DALLAS PARKWAY, DALLAS TX 75254
Paola M Arbour	officer: EVP, Chief Information Officer	14201 DALLAS PARKWAY, DALLAS TX 75254
Cecil D Haney	director	C/O GENERAL DYNAMICS CORPORATION, 11011 SUNSET HILLS ROAD, RESTON VA 20190
Lisa Y Foo	officer: EVP, Commercial Ops	14201 DALLAS PARKWAY, DALLAS TX 75254
R. Scott Ramsey	officer: Principal Accounting Officer	1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202
Saumya Sutaria	officer: Chief Operating Officer	14201 DALLAS PARKWAY, DALLAS TX 75254
Meghan Fitzgerald	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Christopher S. Lynch	director	8200 JONES BRANCH DRIVE, MCLEAN VA 22102
Nadja West	director	1915 REXFORD ROAD, CHARLOTTE NC 28211
Richard J Mark	director	1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103
Roy Blunt	director	2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235
Stephen H Rusckowski	director	C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094